Inhibition of Photohemolysis Induced by m-Chloroperbenzoic Acid by Metal Complexes with SOD-mimetic Activity

Red blood cells (RBCs) are probably the most common target through the damaging action of reactive oxygen species on the cells. The photohemolysis activity of m-chloroperbenzoic acid (CPBA) was concentration- and exposure time-dependent. Twenty minutes photo exposure time and 200?μm of CPBA concentration were optimum to study the effect of generated superoxide (O₂^-) and hydroxyl (^?OH) radicals on RBCs. RBCs lysis photosensitized by CPBA was investigated in the presence of [(VL²O)(VL²H²O)]Cl⁶, [MnL²O]²Cl⁴2H²O, [FeL²Cl²]Cl H²O, [CoL²Cl²]⁴H²O or [ZnL²Cl²]H²O respectively, where L is 2-methylaminopyridine, with SOD-mimetic activities with the aim of ascertaining their protective activity towards the photo induced cell damage. The decrease of photolytic activity caused by these complexes was concentration-dependent and the maximum percentage of protective activity was 75, 70, 68, 57 or 24% for [(VL²O)(VL²H²O)]Cl⁶, [MnL²O]²Cl⁴ 2H²O, [FeL²Cl²]Cl H²O, [CoL²Cl²]⁴H²O or [ZnL²Cl²]H²O complex respectively, against the cell irradiated without addition of metal complexes. The comparison between the decrease of photolytic activity caused by these complexes and their SOD-mimetic activity of these metal complexes showed an appreciable correlation.     

Electrospray mass spectrometry of trans-[Ru(NO)Cl(dpaH)2] (dpaH=2,2′-dipyridylamine) and ‘caged NO’, [RuCl3(NO)(H2O)2]: loss of HCl and NO from positive ions versus NO and Cl from negative ions

The positive ion electrospray mass spectrometry (ESI-MS) of trans-[Ru(NO)Cl)(dpaH)₂]Cl₂ (dpaH=2,2′-dipyridylamine), obtained from the carrier solvent of H₂O–CH₃OH (50:50), revealed 1+ ions of the formulas [Ru^II(NO⁺)Cl(dpaH)(dpa)]⁺ (m/z=508), [Ru^IIICl(dpaH)(dpa⁻)]⁺ (m/z=478), [Ru^II(NO⁺)(dpa)₂]⁺ (m/z=472), [Ru^III(dpa)₂]⁺ (m/z=442), originating from proton dissociation from the parent [Ru^II(NO⁺)Cl(dpaH)₂]²⁺ ion with subsequent loss of NO (17.4% of dissociative events) or loss of HCl (82.6% of dissociative events). Further loss of NO from the m/z=472 fragment yields the m/z=442 fragment. Thus, ionization of the NH moiety of dpaH is a significant factor in controlling the net ionic charge in the gas phase, and allowing preferential dissociation of HCl in the fragmentation processes. With NaCl added, an ion pair, {Na[Ru^II(NO)Cl(dpa)₂]}⁺ (m/z=530; 532), is detectable. All these positive mass peaks that contain Ru carry a signature ‘handprint’ of adjacent m/z peaks due to the isotopic distribution of ¹⁰⁴Ru, ¹⁰²Ru, ¹⁰¹Ru, ⁹⁹Ru, ⁹⁸Ru and ⁹⁶Ru mass centered around ¹⁰¹Ru for each fragment, and have been matched to the theoretical isotopic distribution for each set of peaks centered on the main isotope peak. When the starting complex is allowed to undergo aquation for two weeks in H₂O, loss of the axial Cl⁻ is shown by the approximately 77% attenuation of the [Ru^II(NO⁺)Cl(dpaH)(dpa)]⁺ ion, being replaced by the [Ru^II(NO⁺)(H₂O)(dpa)₂]⁺ (m/z=490) as the most abundant high-mass species. Loss of H₂O is observed to form [Ru^II(NO⁺)(dpa)₂]⁺ (m/z=472). No positive ion mass spectral peaks were observed for RuCl₃(NO)(H₂O)₂, ‘caged NO’. Negative ions were observed by proton dissociation forming [Ru^II(NO)Cl₃(H₂O)(OH)]⁻ in the ionization chamber, detecting the parent 1− ion at m/z=274, followed by the loss of NO as the main dissociative pathway that produces [Ru^IIICl₃(H₂O)(OH)]⁻ (m/z=244). This species undergoes reductive elimination of a chlorine atom, forming [Ru^IICl₂(H₂O)(OH)]⁻ (m/z=208). The ease of the NO dissociation is increased for the negative ions, which should be more able to stabilize a Ru^III product upon NO loss.     

Synthesis and characterization of homologous nickel(II) and palladium(II) complexes with biphosphine monoxide ligands Ph2P(CH2)nP(O)Ph2 (n = 1–3) and pTol2P(CH2)P(O)pTol2

A series of cationic nickel complexes [(η³-methally)Ni(PP(O))]SbF₆ (1–4) [PP(O) = Ph₂P(CH₂)P(O)Ph₂ (dppmO) (1), Ph₂P(CH₂)₂P(O)Ph₂ (dppeO) (2), Ph₂P(CH₂)₃P(O)Ph₂ (dpppO) (3), pTol₂P(CH₂)P(O)pTol₂ (dtolpmO) (4)] has been synthesized in good yields by treatment of [(η³-methally)NiBr]₂ with biphosphine monoxides and AgSbF₆. The ligands are coordinated in a bidentate way. Starting from [(η³-all)PdI]₂ the cationic complexes [(η³-all)PP(O))]Y (8–14). [PP(O) = dppmO, dppeO, dpppO, dtolpmO;Y = BF₄, SbF₆, CF₃SO₃, pTolSO₃] were synthesized in good yields. The coordination mode of the ligand is dependent on the backbone and the anion, revealing a monodentate coordination with dppmO for stronger coordinating anions. The intermediates [(η³-all)Pd(I)(PP(O)-κ¹-P)] (5–7) [PP(O) = dppmO (5), dppeO (6), dtolpmO (7)] were isolated and characterized. Neutral methyl complexes [(Cl)(Me)Pd(PP(O))] (15–18). [PP(O) = dppmO (15), dppeO (16), dpppO (17), dtolpmO (18)] can easily be obtained in high yields starting from [(cod)PdCl₂]. For dppmO two different routes are presented. The structure of [(Me)(Cl)Pd{;Ph₂P(CH₂-P(O)Ph₂-κ²-P,O};] · CH₂Cl₂ (15) with the chlorine atom trans to phosphorus was determined by X-ray diffraction.     

Heterobimetallic chloro bridgedcomplexes of (η:η−C10H16)-ruthenium(IV) with palladium(II), platinum(II), rhodium(III), iridium(III), copper(I) and rhodium(I)

Metathesis of [(η³:η³−C₁₀H₁₆)Ru(Cl) (μ−Cl)]₂ (1) with [R₃P) (Cl)M(μ-Cl)]₂ (M = Pd, Pt), [Me₂NCH₂C₆H₄Pd(μ-Cl)]₂ and [(OC)₂Rh(μ-Cl)]₂ affords the heterobimetallic chloro bridged complexes (η³:η³-C₁₀H₁₆) (Cl)Ru(μ-Cl)₂M(PR₃)(Cl) (M = Pd, Pt), (η³:η³-C₁₀H₁₆) (Cl)Ru(μ-Cl)₂PdC₆H₄CH₂NMe₂ and (η³:η³-C₁₀H₁₆) (Cl)Ru(μ-Cl)₂Rh(CO)₂, respectively. Complex 1 reacts with [Cp^*M(Cl) (μ-Cl)]₂ (M = Rh, Ir), [p-cymene Ru(Cl) (μ-Cl]₂ and [(Cy₃P)Cu(μ-Cl)]₂ to give an equilibrium of the heterobimetallic complexes and of educts. The structures of (η³:η³-C₁₀H₁₆)Ru(μ-Cl)₂Pd(PR₃) (Cl) (R = Et, Bu) and of one diastereoisomer of (η³:η³-C₁₀H₁₆)Ru(μ-Cl)₂IrCp^*(Cl) were determined by X-ray diffraction.     

Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds

The reactions of arene–metal complexes (arene = p-cymene, benzene or pentamethylcyclopentadienyl, metal = Ru, Rh or Os), including 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decanephosphine (pta) and chloro co-ligands, with 9-methylguanine, adenine, and a series of nucleosides were studied in water to ascertain the binding modes. The products were characterized by NMR spectroscopy and electrospray ionization mass spectrometry (ESI-MS). Tandem mass spectrometry was found to provide excellent information on preferential binding sites. In general, the N7 position on guanine (the most basic site) was found to be the preferred donor atom for coordination to the metal complexes. The X-ray structures of the precursor complexes, [(η⁵-C₁₀H₁₅)RhCl(pta-Me)₂]Cl₂, [(η⁶-C₁₀H₁₄)OsCl(pta)₂]Cl, and [(η⁶-C₆H₆)OsCl₂(CH₃CN)], are also reported.     

Synthesis, structure and biological activities of cobalt(II) and zinc(II) coordination compounds with 2-benzimidazole derivatives

In this work we present the synthesis, structural and spectroscopic characterisation of a series of cobalt(II) and zinc(II) coordination compounds with benzimidazole (bz) and its 2-benzimidazole derivatives: 2-aminobenzimidazole (2ab), albendazole (abz) and tris(2-benzimidazolylmethyl)amine (ntb). The compounds were evaluated for their in vitro antimicrobial activity against Staphylococcus aureus, Micrococcus luteus, Salmonella typhi, Pseudomonas aeruginosa, Escherichia coli and Proteus vulgaris. Their cytotoxic activity was also evaluated using human cancer lines, HeLa, HCT-15 and SKLU-1. The halide tetrahedral compounds [Co(bz)₂Br₂] 3, [Zn(2ab)₂Cl₂] · 0.5H₂O 11, [Co(abz)Cl₂(H₂O)] · 3H₂O 14, [Co(abz)Br₂(H₂O)] 15, [Zn(abz)Cl₂(H₂O)] · 3H₂O 17 and [Zn(abz)Br₂(H₂O)] · H₂O 18 displayed similar minimal inhibition concentration (MIC) values against Micrococcus luteus and Escherichia coli, comparable to those of amoxicillin and chloramphenicol. Additionally, 11 showed a wide range of activity towards Gram(+) and Gram(−) microorganisms. The tetradentate ntb and its trigonal bipyramidal cobalt(II) and zinc(II) compounds were active, regardless of the anion present in the complex. Compound [Co(abz)Cl₂(H₂O)] · 3H₂O 14 showed promising activity in HeLa cells, while [Co(ntb)Br]Br · H₂O 21 inhibited Hela and HCT-15 cell lines.     

Variation of DNA photocleavage efficiency for [(TL)2Ru(dpp)]Cl2 complexes where TL=2,2'-bipyridine, 1,10-phenanthroline, or 4,7-diphenyl-1,10-phenanthroline

The complexes [(bpy)₂Ru(dpp)]Cl₂, [(phen)₂Ru(dpp)]Cl₂, and [(Ph₂phen)₂Ru(dpp)]Cl₂ (where dpp = 2,3-bis(2-pyridyl)pyrazine, bpy = 2,2′-bipyridine, phen = 1,10-phenanthroline, Ph₂phen = 4,7-diphenyl-1,10-phenanthroline) have been investigated and found to photocleave DNA via an oxygen-mediated pathway. These light absorbing complexes possess intense metal-to-ligand charge transfer (MLCT) transitions in the visible region of the spectrum. The [(TL)₂Ru(dpp)]²⁺ systems populate ³MLCT states after visible light excitation, giving rise to emissions in aqueous solution centered at 692, 690, and 698 nm for TL = bpy, phen, and Ph₂phen respectively. The ³MLCT states and emissions are quenched by O₂, producing a reactive oxygen species. These complexes photocleave DNA with varying efficiencies, [(Ph₂phen)₂Ru(dpp)]²⁺ > [(phen)₂Ru(dpp)]²⁺ > [(bpy)₂Ru(dpp)]²⁺. The presence of the polyazine bridging ligand will allow these chromophores to be incorporated into larger supramolecular assemblies.     

Molecular structures of Fe(II) complexes with mono- and di-protonated ethylenediamine-N,N,N′,N′-tetraacetate (Hedta and H2edta), as determined by X-ray crystal analyses

The molecular structure of the title complexes [Fe(H₂O)₄][Fe(Hedta)(H₂O)]₂ · 4H₂O (I) and [Fe(H[₂edta)(H₂O)] · 2H₂O (II) have been determined by single-crystal X-ray analyses. The crystal data are as follows: I: monoclinic, P2₁/n, A = 11.794(2), B = 15.990(2), C = 9.206(2) Å, β = 90.33(1)°, V = 1736.1(5) ų, Z = 2 and R = 0.030; II: monoclinic, C2/c, A = 11.074(2), B = 9.856(2), C = 14.399(2) Å, β = 95.86(1)°, V = 1563.3(4) ų, Z = 4 and R = 0.025. I is found to be isomorphous with the Mn^II analog reported earlier and to contain a seven-coordinate and approximately pentagonal-bipyramidal (PB) [Fe^II(Hedta)(H₂O]⁻ unit in which Hedta acts as a hexadentate ligand. The [Fe^II(H₂edta)(H₂O)] unit in II has also a seven-coordinate PB structure with the two protonated equatorial glycine arms both remaining coordinated, and thus bears a structural resemblance to the seven-coordinate [Co^II(H₂edta)(H₂O)] reported previously.     

The dicarbonylation of diiodomethane to malonate esters catalysed by triethylphosphine complexes of rhodium

Rhodium complexes, in the presence or absence of PEt₃, catalyse the carbonylation of CH₂I₂ to dialkylmalonates in the presence of alcohols (ROH, R=Me, Et, Pr¹, Bu) with side products from reactions in EtOH being CH₂(OEt)₂, EtI and traces of EtCO₂Et and EtOAc. The active species when using PEt₃ is shown to be [RhI(CO)(PEt₃)₂], formed via [Rh(OAc)(CO)(PEt₃)₂] from [Rh₂(OAc)₄ · 2MeOH] and PEt₃. Mechanistic studies show that the first step of the catalytic cycle is oxidative addition of CH₂I₂ to give [Rh(CH₂I)I₂(CO)(PEt₃)₂], but that insertion of CO into the Rh---CH₂I bond gives an iodoacyl complex which is unstable. The analogous [Rh(COCH₂X)X₂(CO)(PEt₃)₂], (X=Cl or Br) have been synthesised by oxidative addition of XCH₂COX to [RhX(CO)(PEt₃)₂] and fully characterised (by X-ray crystallography, for X=Cl). [Rh(COCH₂Br)Br₂(CO)(PEt₃)₂] has also been formed from reaction of [Rh(COCH₂Cl)Cl₂(CO)(PEt₃)₂] with excess NaBr. However, the analogous reaction with NaI does not give the iodoethanoyl complex, but rather [RhI₃(CO)(PEt₃)₂] and its decomposition products. It is proposed that [Rh(COCH₂I)I₂(CO)(PEt₃)₂] is unstable towards loss of I⁻ to form the ketene complex, [RhI₂(CH₂=C=O)(CO)(PEt₃)₂]I, which is transformed into [Rh(COCH₂CO₂Et)I₂(CO)(PEt₃)] by nucleophilic attack of ethanol at the central C atom, followed by CO insertion into the Rh---C bond. An analogue, [Rh(COCH₂CO₂Et)Cl₂(CO)(PEt₃)₂], has been isolated by oxidative addition of EtO₂CCH₂COCl across [RhCl(CO)(PEt₃)₂], and characterised both spectroscopically and crystallographically. In refluxing ethanol, [Rh(COCH₂CO₂Et)Cl₂(CO)(PEt₃)₂] produces diethylmalonate and [RhCl(CO)(PEt₃)₂], thus completing the catalytic cycle. Possible pathways of deactivation of the catalyst to give [RhI₃(CO)(PEt₃)₂] are discussed. One involves the reaction of ketene with ethanol to give EtOAc, whilst the others involve protonation of the Rh---Z bond in [RhZI₂(CO)(PEt₃)₂] (where Z =CH₂I, CH₂CO₂Et or H) by HI. The isolation of CH₂DCO₂Et, when carrying out the reaction in EtOD, is consistent with all of these deactivation pathways except protonation of [RhHI₂(CO)(PEt₃)₂].     

Synthesis, anticancer activities, interaction with DNA and mitochondria of manganese complexes

Two new complexes [(Etdpa)MnCl₂] and [(Adpa)Mn(Cl)(H₂O)] (Etdpa = ethyl bis(2-pyridylmethyl)amino-2-propionate; Adpa = bis(2-pyridylmethyl)amino-2-propionic acid) were synthesized and characterized by spectral methods. The crystal structure of [(Etdpa)MnCl₂] shows that the Mn(II) atom is coordinated by three N atoms (N1, N2, N3), one oxygen atom (O1) of the ligand (Etdpa) and two chloride atoms (Cl1, Cl2), forming a distorted octahedral geometry. The binding interaction between ct-DNA and the synthesized complexes was relatively weak, but they can inhibit the induced swelling of Ca²⁺-loaded mitochondria in a dose-dependent manner. The [(Adpa)Mn(Cl)(H₂O)] can cause the obvious decrease of mitochondria membrane potential. The MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenpyltetra-zolium bromide) assay shows that the two Mn(II) complexes are more active against cancer cells. Especially [(Adpa)Mn(Cl)(H₂O)] can inhibit the proliferation of glioma cells with IC₅₀ 9.5 μM. Experimental results indicate that the [(Adpa)Mn(Cl)(H₂O)] could be a new potential antitumor complex to target the mitochondria.     

Platinum(II) complexes of 4-methoxy- and 4-chlorobenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect

The complexes [Pt(NH₃)(pmbah)Cl₂], [Pt(NH₃)(pcbah)Cl₂], [Pt(pmbah₂X₂] and [Pt(pcbah)₂X₂] (pmbah = 4-methoxybenzoicacid hydrazide, pcbah = 4-chlorobenzoic acid hydrazide; X = Cl, Br, I) have been synthesized and characterized by elemental analysis, electric conductivity, ¹H NMR, IR, and electronic spectra. A cis-square planar structure with hydrazide ligands coordinated via the NH₂ groups has been proposed for these compounds. The complexes, but not the free ligands, have shown a strong growth inhibitory effect in Friend leukemia cells in vitro, most of which are more active than cisplatin.     

A series of heteroleptic complexes of the type fac-[MnL2] [H2L=derivatives of N-(2-hydroxybenzyl)glycine or N-(5-nitro-2-hydroxybenzyl)sarcosine] possessing unusual Mn(III) co-ordination spheres

The mononuclear manganese(III) complexes [C₅H₁₀NH₂][MnL₂] [L²⁻=a substituted N-(2-hydroxybenzyl)glycinate (hbg²⁻) viz. 3,5-dibromo- (3,5-Br-hbg²⁻), 3,5-dichloro- (3,5-Cl-hbg²⁻), 3-methyl-5-chloro- (3,5-Me,Cl-hbg²⁻), 5-bromo- (5-Br-hbg²⁻), 5-chloro- (5-Cl-hbg²⁻), 5-nitro- (5-NO₂-hbg²⁻) or N-(5-nitro-2-hydroxybenzyl)sarcosine (5-NO₂-hbs²⁻)] have been synthesised by reaction of the appropriate ligand with manganese(II) perchlorate under ambient conditions in a 2:1 molar ratio using piperidine as base. The structures of three of these complexes, [C₅H₁₀NH₂][Mn(3,5-Cl-hbg)₂] (2), [C₅H₁₀NH₂][Mn(5-NO₂-hbg)₂] (6) and [C₅H₁₀NH₂][Mn(5-NO₂-hbs)₂] (7) have been elucidated by single-crystal X-ray crystallography and each displays two similar, independent [MnL₂]⁻ ions in the asymmetric unit linked via piperidinium cations through hydrogen bonding. The ligands co-ordinate in a facial tridentate fashion with the three donor atoms being the phenolate and carboxylate oxygens and the amine nitrogen. The geometry at the Mn centres is compressed rhombic octahedral consistent with a pseudo-Jahn–Teller compression along the Mn–O(phenolate) axis. Mean bond lengths are in the ranges 1.886–1.889 Å for the Mn–O(phenolate), 2.062–2.125 Å for the Mn–O(carboxylate) and 2.091–2.184 Å for the Mn–N(amine) distances. The magnetic susceptibility and electronic and IR spectroscopic data are discussed with reference to the crystal structures.     

Triphenylbismuth seven-coordinate complexes of molybdenum(II) and tungsten(II)

The seven-coordinate complexes [MI₂(CO)₃(NCMe)₂] (M = Mo and W) react with one equivalent of BiPh₃ in CH₂Cl₂ at room temperature to give the monoacetonitrile complexes [MI₂(CO)₃(NCMe)(BiPh₃)]. The molybdenum complex [MoI₂(CO)₃(NCMe)(BiPh₃)] after stirring in CH₂Cl₂ at room temperature for 5 h affords the iodide-bridged dimer [Mo(μ-I)I(CO)₃(BiPh₃)]₂, whereas the tungsten complex [WI₂(CO)₃(NCMe)(BiPh₃)] does not appear to dimerise even after stirring for 48 h in CH₂Cl₂ at room temperature. Reaction of [MI₂(CO)₃(NCMe)₂] with two equivalents of BiPh₃ gives the bistriphenylbismuth compounds [MI₂(CO)₃(BiPh₃)₂] in good yield. The new mixed ligand complexes [MI₂(CO)₃L(BiPh₃)] were prepared either by reaction of [MI₂(CO)₃(NCMe)(BiPh₃)]in situ with one equivalent of L(L = P(OPh)₃), or an in situ reaction of [MI₂(CO)₃(NCMe)L] (L = PPh₃ and SbPh₃; and L = AsPh₃ and PPh₂Cy (for M = Mo only) with an equimolar quantity of BiPh₃. Reaction of [MoI₂(CO)₃(NCMe)(BiPh₃)] with one equivalent of 2,2′-bipyridyl (bipy) in CH₂Cl₂ at room temperature afforded the cationic complexes [MoI(CO)₃(bipy)(BiPh₃)]I in good yield. The complex [WI₂(CO)₃(NCMe)(BiPh₃)] (prepared in situ) reacts with two equivalents of NaS₂CNMe₂·2H₂O to eventually give the non-triphenylbismuth containing product [W(CO)₃(S₂CNMe₂)₂] in high yield.     

Synthesis, characterization, and reactivity of organometallic Zr(IV) carboxylate complexes

A series of zirconium(IV) complexes, [ZrX₂(XDK)], where XDK is the constrained carboxylate ligand m-xylylenediamine bis(Kemp's triacid imide), were prepared and structurally characterized. The solid state structure of the mononuclear carboxylate alkyl complex [Zr(CH₂Ph)₂(XDK)] reveals that one benzyl group is bonded in an η²-fashion to the metal center. The reactivity of [Zr(CH₂Ph)₂(XDK)] displays its electrophilic character toward nucleophiles strong enough to displace the η²-benzyl group. Thus, weak sigma donor ligands such as CO, alkynes and anilines do not react, whereas strong sigma donors, such as pyridines and isocyanides, rapidly form the monoadduct [Zr(CH₂Ph)₂(4-tert-butylpyridine)(XDK)] and [Zr{η²-2,6-Me₂PhNCCH₂Ph}₂(XDK)], an η²-iminoacyl derivative, respectively. Attempts to prepare zirconium amido complexes with H₂XDK generally afforded the eight-coordinate [Zr(XDK)₂] complex but use of the small amido ligand precursorZr(NMe₂)₄ allowed [Zr(NMe₂)₂(4-tert-butylpyridine)(XDK)] to be isolated in good yield.     

Nitrogen, sulfur and oxygen donor adducts with copper(II) complexes of antitumor 2-formylpyridinethiosemicarbazone analogs: Physicochemical and cytotoxic studies

The preparation of N-, S- and O-donor ligand adducts with CuX⁺(HX=6-methyl-2-formylpyridinethiosemicarbazone (6HL); 2-formylpyridine-2^′-methylthiosemicarbazone (2′L); 2-formylpyridine-4′-methylthiosemicarbazone (4′HL)) is described. The N-donors, 2,2′-bipyridyl (bipy), 4-dimethylaminopyridine (dmap) give the complexes [Cu(6L)(bipy)]PF₆, [Cu(6L)(bipy)]Cl·5H₂O, [Cu(4′L)(bipy)]PF₆, [Cu(6L)(dmap)₂]PF₆·2.5 H₂O and [Cu(4′L)(dmap)₂]PF₆·H₂O which have been characterized by physical and spectroscopic techniques. Pentafluorothiophenolate (pftp) gives S-donor complexes [CuX(pftp)] (X=6L and 4′L) and thiolato co-ordination is proposed on the basis of spectroscopic evidence. Paratritylphenolate (ptp) and HPO²⁻₄ give O-donor complexes [Cu(6L)(ptp)], [Cu(4′L)(ptp)], [{Cu(6L)}₂HPO₄]·4H₂O, and [{Cu(4^′L)}₂HPO₄]·5H₂O which have been characterized by physical and spectroscopic techniques, as have the precursor complexes [Cu(6L)(CH₃COO)]·H₂O, [Cu(4′L)(CH₃COO)], Cu(6HL)(CF₃COO)](CF₃COO)·0.5H₂O, [Cu(4′HL)(CF₃COO)](CF₃COO), [Cu(2′L)Cl₂] and [Cu(2′L)(NO₃)₂]. Protonation constants for the ligands and some of their complexes have been determined. 2-Formylpyridinethiosemicarbazone (HL) complexes of silver, gold, zinc, mercury, cadmium and lead are also discussed. Cytotoxicity against the human tumor cell line HCT-8 and antiviral data for selected compounds are presented.     

Gold in organic synthesis Part 2. Preparation of benzyl-alkyl and-arylketones via C---C coupling

Reaction of [Au(η²-Ar){CH₂C(O)R}Cl] (Ar=C₆H₄N=N- Ph-₂, R=Me, C₆H₂(OMe)₃-3′,4′,5′; Ar=C₆H₃(N=NC₆H₄Me- 4′)-2, Me-5, R=Me) with PPh₃ and NaClO₄·H₂O (1:2:1) at room temperature, leads to reductive elimination giving [Au(PPh₃)₂]ClO₄ and the corresponding carbon-carbon coupling product ArCH₂C(O)R. A similar process takes place when complexes [Au(η²-Ar){CH₂C(O)R}(PPh₃)Cl] are refluxed in tetrahydrofuran, through elimination of [Au(PPh₃)Cl].     

Synthesis, structure, and heterogeneous catalytic activity of tungsten chalcogenide cubane cluster containing alkaline earth metal complex

A new compound containing a cubane tungsten chalcogenide cluster [W₄(μ₃-Te)₄(CN)₁₂]⁶⁻ and Ca²⁺ complex units has been prepared by the reaction of aqueous solution of K₆[W₄(μ₃-Te)₄(CN)₁₂] · 5H₂O with the solution of a Ca(NO₃)₂ and phen(1,10-phenanthroline) (1:2 molar ratio) in a solvent mixture of H₂O/EtOH. The structure of [{Ca(phen)₂(H₂O)}{Ca(phen)(H₂O)₄}{Ca(phen)₂(H₂O)₃}][W₄Te₄(CN)₁₂] · 5H₂O 1 has been determined by X-ray crystallography. Compound 1 contains [{Ca(phen)(H₂O)₄}{Ca(phen)₂(H₂O)₃}][W₄(μ₃- Te)₄(CN)₁₂] units bridged by {Ca(phen)₂(H₂O)}²⁺ units to form an one-dimensional zigzag chain structure. Interestingly, compound 1 showed a heterogeneous catalytic activity in the transesterification of a range of esters with methanol under the mild conditions. Moreover, it can be reused without any loss of activity through 10 runs with ester.     

Fluoro-hydrido-oxo and other fluoro-oxo complexes of rhenium (V) containing a triphosphine ligand

The fluoro-hydrido-oxo complex [Re(F)(H)(O)Cyttp]⁺ (3, Cyttp = PhP(CH₂CH₂CH₂PCy₂)₂) was prepared in high yield from [Re(H₂)H₄Cyttp]SbF₆ (1(SbF₆), NaSbF₆ and acetone in toluene at reflux. Reaction chemistry of 3 has been studied and, where appropriate, compared with that of the related dihydrido-oxo complex [ReH₂(O)Cyttp]⁺ (2). Unlike 2, which readily reacts with both CO and SO₂, 3 was found to be inert to these reagents under comparable conditions. However, 3(SbF₆) reacts with NaSbF₆ at elevated temperature to afford the difluoro-oxo complex [ReF₂(O)Cyttp]⁺ (4). 4 undergoes fluoride substitution by Cl⁻ or Br⁻ to yield [Re(X)(F)(O)Cyttp]⁺ (X = Cl (5, Br (6)). 5 can also be obtained by treatment of 6(BPh₄) with LiCl. All of these complexes contain mer-Cyttp, and 3–6 contain trans fluoride and oxide ligands as inferred from spectroscopic data.     

Photochemistry of platinum phosphine complexes. Perspective in C---H bond activation

The photochemistry of the diphosphino Pt(II) hydrides [LPtH₂] (L=(t-Bu)₂P(CH₂)₂P(t-Bu)₂ (7); L=(t-Bu)₂P(CH₂)₃P(t-Bu)₂ (8);L=(t-Bu)(Ph)P(CH₂)₂P(Ph)(t-Bu) (9)) is reported. The primary photoevent is the dissociation of H₂ and formation of the 14-e [LPt] species. These coordinatively unsaturated intermediates provide a versatile entry point into the C---H bond activation of hydrocarbons. [LPt] reacts with benzene in an oxidative addition reaction to yield [LPt(H)(C₆H₅)] complexes. The importance of the metal centre and ancillary ligation in the C---H bond activation is discussed.     

Iron(II)/reductant(DH2)-induced activation of dioxygen for the hydroxylation and ketonization of hydrocarbons; Mimics for the cytochrome P-450 hydroxylase/reductase system

Several metal complexes Fe^II(DPAH)₂ (DPAH₂ = 2,6-dicarboxyl pyridine), Fe^II(PA)₂ (PAH = picolinic acid), Fe^II(bpy)₂²⁺, Fe^II(OPPh₃)₄₂₊, (Cl₈TPP)Fe^IIIX (X=Cl, OH, SCH₂Ph) [Cl₈TPP = tetrakis (2,6-dichlorophenyl)porp Fe^IIICl (TPP = tetraphenylporphyrin), and Cu^I(tpy)₂⁺ (tpy = 2,2′–6,2″-terpyridine) in combination with one of several reductants [DH₂; PhNHNHPh (mimic of dihydroflavin), PhNHNH₂, ascorbic acid (H₂asc), and PhCH₂SH (model ligand for cysteine residue)] catalytically activate O₂ (1 atm) for the hydroxylation of saturated hydrocarbons (e.g. c-C₆H₁₂ → c-C₆H₁₁OH). This chemistry closely parallels that of cytochrome P-450 proteins, and both appear to involve a Fenton-like reactive intermediate), [L_xFeOOH(DH)]. With cyclohexene as the substrate the dominant product is its ketone (as well as significant amounts of its hydroperoxide), 1,4-Cyclohexadiene (with two double-allylic carbon centers) undergoes dehydrogenation to give benzene, but also yields substantial amounts of phenol via ketonization of an allylic carbon. The 1:1 Fe^II(bpy)₂²⁺/(PhNHNH₂ or H₂asc), Fe^IIPA₂/H₂asc, and (Cl₈TPP)Fe^IIICl/PhNHNH₂ combinations initiate the autoxidation of 1,4-cyclohexadiene with turnover numbers (moles of product per mole of reductant) from 71 to 26, respectively (-tocophenol reduces the turnover numbers by 20–80 %). With respect to aerobic biology, the present results indicate that dysfunctional transition metals (degradation products of metalloproteins) in combination with biological reductants activate O₂ for reaction with organic substrates. The level of activation is similar to that for Fenton reagents and cytochrome P-450 hydroxylases. Hence, dysfunctional transition metals, reductants, and O₂ are a hazardous combination within a biological matrix.